Max Chat
CANbridge Pharmaceuticals Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 37.2 | -100% | -2.45 | -100% |
| P/S |
|
0.6616 | 4.03 | -83.59% |
|
|
| P/BV |
|
-0.1187 | 1.93 | -106.13% |
|
|
| P/FCF |
|
-5.72 | -10.12 | -43.51% |
|
|
| Ev/Ebitda |
|
-0.83 | 2.91 | -128.54% |
|
|
| Ev/S |
|
0.9005 | 7.34 | -87.73% |
|
|
| Ev/FCF |
|
-0.6256 | -11 | -94.31% |
|
|
| E/P |
|
-0.6322 | 0.0327 | -2030.5% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-534.18 | 1.46 | -36694.57% | -2348.15 | -77.25% |
| ROE |
|
172.13 | 3.98 | 4229.65% |
|
|
| ROA |
|
-172.84 | 2.89 | -6085.54% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-520.1 | 10.86 | -4888.61% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0668 | 0.3827 | -117.46% | -0.2515 | -73.44% |
| Nеt Debt/Ebitda |
|
-0.0447 | -0.2202 | -79.68% |
|
|
| Debt/Ratio |
|
0.26 | 0.132 | 96.93% |
|
|
| Debt/Equity |
|
-1.25 | 0.6875 | -281.26% |
|
|
| Debt/Net Income |
|
-0.0686 | 2.61 | -102.63% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 4.32 | -100% | 2.33 | -100% |
| Number of years of dividend growth |
|
0 | 1.23 | -100% | ||
| DSI |
|
0.7 | 0.5482 | 27.69% |
|
|
| Average dividend growth |
|
-13.89 | -2.77 | 400.85% |
|
|
| Average percentage for 5 years |
|
2.33 | 4.29 | -45.63% |
|
|
| Average percentage for payments |
|
27.03 | 34.1 | -20.73% |
|
|
| Difference from average difference in sector |
|
-4.32 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
607.31 | -94.75 | -740.96% | ||
| Growth impulse Ebitda in 5 years |
|
60.61 | -45.56 | -233.03% | ||
| Growth impulse Net Income in 5 years |
|
-47.68 | -111.86 | -57.38% | ||
| Growth impulse FCF in 5 years |
|
-59.85 | -138.06 | -56.65% | ||
| Growth impulse EPS in 5 years |
|
210.72 | -139.77 | -250.76% |
IP Score
4.92/10
